Mersana Therapeutics
MRSN
MRSN
131 hedge funds and large institutions have $955M invested in Mersana Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
16% less capital invested
Capital invested by funds: $1.14B → $955M (-$189M)
99% less call options, than puts
Call options by funds: $37K | Put options by funds: $3.75M
Holders
131
Holding in Top 10
3
Calls
$37K
Puts
$3.75M
Top Buyers
| 1 | +$14.1M | |
| 2 | +$12.3M | |
| 3 | +$11.6M | |
| 4 |
BlackRock
New York
|
+$11.1M |
| 5 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$9.93M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$11.7M | |
| 3 | -$8.91M | |
| 4 |
Goldman Sachs
New York
|
-$7.88M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.78M |